The Icahn School of Medicine at Mount Sinai is hosting its fifth annual SINAInnovations conference on October 25 – 26, 2016. This year’s theme “Therapeutic Discovery” will include keynote addresses, short talks, panel discussions and lunchtime breakout sessions featuring international thought leaders across the range of relevant domains. Sessions and lectures will include: Drug Development in Academia; Target Identification and Validation; Industry-Academic Medical Center Partnerships; Funding Drug Discovery; Health Disparities and Drug Discovery for the Developing World; Clinical Trial Advances and Novel First-in-man Approaches, and Therapeutic Frontiers in Oncology. The conference will define the astonishing advances in drug discovery, and outline solutions to overcome obstacles to progress.
Suprotik (Protik) Basu is CEO of the Office of the UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria. He concurrently serves as CEO of the Global Health Alliance, an initiative to bring business leaders and business approaches into the effort to achieve the world's global health goals.
George Church is Professor of Genetics at Harvard Medical School and Director of PersonalGenomes.org, which provides the world's only open-access information on human Genomic, Environmental & Trait data (GET). His 1984 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing & barcoding. These led to the first genome sequence (pathogen, Helicobacter pylori) in 1994.
Karl Deisseroth is the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, and Investigator of the Howard Hughes Medical Institute. He received his undergraduate degree from Harvard, his PhD from Stanford, and his MD from Stanford; he also completed postdoctoral training, medical internship, and adult psychiatry residency at Stanford, and he is board-certified by the American Board of Psychiatry and Neurology.
Manolis Kellis is an Associate Professor of Computer Science at MIT, a member of the Computer Science and Artificial Intelligence Laboratory and of the Broad Institute of MIT and Harvard, where he directs the MIT Computational Biology Group (compbio.mit.edu). His group has recently been funded to lead the integrative analysis efforts of the modENCODE project for Drosophila melanogaster, and also for integrative analysis of the NIH Epigenome Roadmap Project.
Dr. Pardoll is an Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics at the Johns Hopkins University, School of Medicine. He is the Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and Co-Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
2016 Event Organizers: Scott L. Friedman, Lakshmi A. Devi, Robert J. Devita, Janice L. Gabrilove, Paul J. Kenny, Erik Lium, Miriam Merad
Our conference also featured opportunities for scholarly and social exchange, inspiration, and a little friendly competition.
Trainee Forum and Networking Reception
This dynamic program was comprised of panels, didactic lectures, the first Sinai Young Innovators Pitch Competition, and networking reception, and developed exclusively for ISMMS students and postdoctoral trainees at the Mount Sinai Health System.
Mount Sinai Innovation Awards
These annual awards recognize either individual or collaborative investigators in the Mount Sinai Health System whose research has the potential to make significant commercial or health impacts. The first-ever award recipient(s) were honored at the 2015 conference.
This timeline showcases Mount Sinai Health System’s long history of groundbreaking firsts, from improved treatments for cancer to genetic engineering and biotechnology.
Check out last year's exciting program and our list of event speakers.